Currency converter
News Feed
News Search Topics
Use filter
You can filter your feed,
by choosing only interesting

ideaPoint, Inc. Announces Launch of Multi-Sponsor Portal

January 09, 2014, 9:00 updated at: January 09, 2014, 12:04 UTC+3
Initiative designed to facilitate data sharing in support of advancing biomedical research
Material has 1 page

QUINCY, Massachusetts, Jan. 2, 2014 /PRNewswire/ -- ideaPoint, Inc., a leading provider of partnering and collaboration systems for global enterprises, today announced the availability of a new portal providing a secure system for researchers to request access to anonymized, patient-level clinical trial data provided by sponsor organizations ( Study sponsors who have committed to provide data through the site currently include Boehringer Ingelheim, GlaxoSmithKline, Roche, Sanofi and ViiV Healthcare.

With extensive experience providing online collaboration solutions for global companies, ideaPoint powers the technology behind the new site's secure request and evaluation process. 

As researchers continue to search for treatments and cures to some of society's biggest medical challenges, the opportunity to seek scientific insights that may lead to potential improvements in patient care by conducting further research with clinical trial data has been universally recognized. For the first time, researchers can select studies of interest from multiple sponsors across multiple disease areas and submit a single research proposal through a user-friendly portal. Research proposals to access data are reviewed by an Independent Review Panel who decides whether access should be provided. The panel reviews the proposed science, publication plans, conflicts of interest and the qualifications of the research team. Those involved in this initiative envision transitioning administration and review of future proposals to an independent third party as soon as possible. The site includes easy-to-follow videos and guides on how to use the portal and submit a proposal, available at

In addition to research proposals to request data from clinical trials already listed on the site, researchers can also submit inquiries to some study sponsors to ask about the availability of data from studies not yet listed. Following approval by the Independent Review Panel, researchers are asked to sign a Data Sharing Agreement. A summary of the requirements in this agreement and an agreement template are provided on the site. 

"The design and development of this user-friendly site is an outgrowth of our collaboration and partnering software. Supporting this need was a natural expansion of our work with life science, academic and non-profit organizations, and we are pleased to work with representatives from the sponsor organizations to achieve this milestone," said Scott Shaunessy, CEO and founder of ideaPoint. "Our solution is highly configurable and will allow the functionality to expand as the initiative matures over time."

The portal currently lists multiple studies available from the sponsor organizations. It has been designed with a flexible configuration so that other industry, academic and non-profit sponsors can join and include their studies. Those interested should contact for more information.

ideaPoint and the sponsors who have committed to the site believe this is an important step towards providing greater access to patient-level data in support of biomedical research, and look forward to continued and expanded collaboration within the research community as this initiative evolves over time.


About ideaPoint

ideaPoint, Inc. is an enterprise software provider that helps global Life Science companies accelerate quality decisions on innovation opportunities that have a material impact on their business.

Since its launch in 2008, ideaPoint has delivered software solutions to industry-leading Pharmaceutical, Biotechnology and Medical Device organizations to capture and assess opportunities for collaboration, licensing and acquisition, venture investing, and other partnering models that create growth through new products, new services and new business creation.


Media Inquiries

Please contact Lynn Blenkhorn at: or +1-508-851-0930

Показать еще
In other media